Everand Logo

Welcome to Everand!

  • Los Angeles Times

    One of the most promising drugs for Alzheimer's disease fails in clinical trials

    by Melissa Healy, Los Angeles Times Jan 10, 2018 3 minutes

    To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

    An experimental drug called idalopirdine failed to help people with mild to moderate Alzheimer's disease in a trio of trials that involved 2,525 patients in 34 countries. Not only did the drug fail to bring about any meaningful change in cognitive tests that are widely used in diagnosing and tracking the progress

    You’re reading a preview, subscribe to read more.

    More from Los Angeles Times

    Los Angeles Times7 min read
    Indie Creatures To The Core, David And Nathan Zellner Cut Their Own Path Through The Wild
    A family makes their way through a woodland forest, eventually stopping to set up camp. They have something to eat, go to sleep and then get up to do it all over again. Except this isn't a family on a wilderness getaway. It's a group of shaggy, mythi
    Los Angeles Times7 min read
    In Ukraine's Old Imperial City, Pastel Palaces Are In Jeopardy, But Black Humor Survives
    ODESA, Ukraine — On a cool spring morning, as water-washed light bathed pastel palaces in the old imperial city of Odesa, the thunder of yet another Russian missile strike filled the air. That March 6 blast came within a few hundred yards of a convoy
    Los Angeles Times2 min read
    Kendrick Lamar Responds To Drake In New Diss Track 'Euphoria'
    LOS ANGELES — Kendrick Lamar is having his say. Again. A week and a half after Drake dropped two songs in which he insulted the Compton-born rapper — diss tracks Drake released after Lamar attacked him last month in the song "Like That" — Lamar retur

    Related Books & Audiobooks